These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 17716074)
21. The obesity epidemic and its impact on hypertension. Nguyen T; Lau DC Can J Cardiol; 2012 May; 28(3):326-33. PubMed ID: 22595448 [TBL] [Abstract][Full Text] [Related]
22. Diets, drugs, exercise, and behavioral modification: Where these work and where they do not. Kushner R Surg Obes Relat Dis; 2005; 1(2):120-2. PubMed ID: 16925226 [No Abstract] [Full Text] [Related]
23. Obesity and cardiovascular disease: pathogenic mechanisms and potential benefits of weight reduction. Douketis JD; Sharma AM Semin Vasc Med; 2005 Feb; 5(1):25-33. PubMed ID: 15968577 [TBL] [Abstract][Full Text] [Related]
24. Weight loss as a treatment for nonalcoholic fatty liver disease. Clark JM J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S39-43. PubMed ID: 16540766 [TBL] [Abstract][Full Text] [Related]
32. Body weight, self-perception and mental health outcomes among adolescents. Ali MM; Fang H; Rizzo JA J Ment Health Policy Econ; 2010 Jun; 13(2):53-63. PubMed ID: 20919592 [TBL] [Abstract][Full Text] [Related]
33. Medical management of obesity. Klein S Surg Clin North Am; 2001 Oct; 81(5):1025-38, v. PubMed ID: 11589243 [TBL] [Abstract][Full Text] [Related]
34. Obesity and the elderly. Mathus-Vliegen EM J Clin Gastroenterol; 2012 Aug; 46(7):533-44. PubMed ID: 22772735 [TBL] [Abstract][Full Text] [Related]
35. What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice. Astrup A; Lundsgaard C Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():29-34. PubMed ID: 9792479 [TBL] [Abstract][Full Text] [Related]
36. How to evaluate and treat obesity. Minnesota Medical Association Obesity Task Force Minn Med; 2005 Sep; 88(9):40-6. PubMed ID: 16475412 [TBL] [Abstract][Full Text] [Related]
37. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder. Appolinario JC; Bacaltchuk J; Sichieri R; Claudino AM; Godoy-Matos A; Morgan C; Zanella MT; Coutinho W Arch Gen Psychiatry; 2003 Nov; 60(11):1109-16. PubMed ID: 14609886 [TBL] [Abstract][Full Text] [Related]
38. [Effect of weight loss on blood pressure]. Bönner G MMW Fortschr Med; 2007 Nov; 149(48):44-7; quiz 48. PubMed ID: 18161437 [TBL] [Abstract][Full Text] [Related]
39. Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study. Mathus-Vliegen EM; Eur J Clin Nutr; 2005 Aug; 59 Suppl 1():S31-8; discussion S39. PubMed ID: 16052193 [TBL] [Abstract][Full Text] [Related]
40. Croatian experience with sibutramine in the treatment of obesity--multicenter prospective study. Stimac D; Ruzić A; Majanović SK Coll Antropol; 2004 Jun; 28(1):215-21. PubMed ID: 15636078 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]